...
首页> 外文期刊>American Journal of Physiology >The monocrotaline model of pulmonary hypertension in perspective
【24h】

The monocrotaline model of pulmonary hypertension in perspective

机译:肺动脉高压的单crocroline模型的观点

获取原文
获取原文并翻译 | 示例

摘要

Severe forms of pulmonary arterial hypertension (PAH) are characterized by various degrees of remodeling of the pulmonary arterial vessels, which increases the pulmonary vascular resistance and right ventricular afterload, thus contributing to the development of right ventricle dysfunction and failure. Recent years have seen advances in the understanding of the pathobiology of PAH; however, many important questions remain unanswered. Elucidating the pathobiology of PAH continues to be critical to design new effective therapeutic strategies, and appropriate animal models of PAH are necessary to achieve the task. Although the monocrotaline rat model of PAH has contributed to a better understanding of vascular remodeling in pulmonary hypertension, we question the validity of this model as a preclinically relevant model of severe plexogenic PAH. Here we review pertinent publications that either have been forgotten or ignored, and we reexamine the monocrotaline model in the context of human forms of PAH.
机译:严重形式的肺动脉高压(PAH)以肺动脉血管的各种程度的重构为特征,这会增加肺血管阻力和右心室后负荷,从而导致右心室功能障碍和衰竭的发展。近年来,人们对PAH的病理生物学认识有所进步。但是,许多重要问题仍未得到解答。阐明PAH的病理生物学对于设计新的有效治疗策略仍然至关重要,而适当的PAH动物模型对于实现该任务是必不可少的。尽管PAH的单crocrotaline大鼠模型有助于更好地了解肺动脉高压中的血管重塑,但我们质疑该模型作为严重丛生PAH的临床前相关模型的有效性。在这里,我们回顾了已经被遗忘或忽略的相关出版物,并在人类形式的PAH的背景下重新审视了单crocrotaline模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号